Brief: Aravive Receives IND Clearance For Phase 1B/Phase 2 Clinical Trial Of AVB-500

Aravive

13/01/2020 13:11

Jan 13 (Reuters) - Aravive Inc  ARAV.O :
    * ARAVIVE RECEIVES IND CLEARANCE FOR PHASE 1B/PHASE 2
CLINICAL
TRIAL OF AVB-500 IN PATIENTS WITH CLEAR CELL RENAL CELL
CARCINOMA

Source text for Eikon:  ID:nGNX1KnlJG 
Further company coverage:  ARAV.O 

 ((Reuters.Briefs@thomsonreuters.com;))